CAS NO: | 945966-46-1 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
500mg | 电议 |
生物活性 | Apararenone (MT-3995) is a novel non-steroidalmineralocorticoid receptorantagonists under development for the treatment of diabetic nephropathies and non-alcoholic steatohepatitis. | ||||||||||||||||
IC50& Target | Mineralocorticoid receptor[1] | ||||||||||||||||
体内研究 (In Vivo) | Recently, a phase II clinical trial has been initiated among patients with non-alcoholic steatohepatitis (NASH) in Japan[1]. | ||||||||||||||||
Clinical Trial | |||||||||||||||||
分子量 | 364.39 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C17H17FN2O4S | ||||||||||||||||
CAS 号 | 945966-46-1 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : ≥ 125 mg/mL(343.04 mM) *"≥" means soluble, but saturation unknown. 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |